United StatesÚltimas notícias

PNC Asset Management Chief Investment Officer Amanda Agati sees "a little bit of steam coming out of the market rally sails." She speaks on "Bloomberg Open Interest."

Parker Hannifin (NYSE:PH) has signed a definitive agreement to acquire CIRCOR Aerospace from KKR and CIRCOR International, Inc. for a cash purchase price of $2.55 billion, marking a significant expansion for the industrial giant's flight-critical components division.

Hovnanian Enterprises (NYSE:HOV) reported a small net loss for its second fiscal quarter that nevertheless came in ahead of internal operating guidance, as resilient homebuyer traffic helped the national homebuilder mitigate ongoing margin compression and affordability hurdles.

European Economy Commissioner Valdis Dombrovskis says the euro area is facing a "stagflationary shock" as real GDP forecasts for 2026 dip, and inflation is seen accelerating beyond the European Central Bank's 2% target. Dombrovskis spoke to Bloomberg's Oliver Crook in Brussels after the European Union's executive arm released its Spring 2026 Economic Forecast.

FedEx President and CEO Raj Subramaniam recounts how Fred Smith, the company's founder, unexpectedly asked him to become CEO during a flight to Los Angeles and later gave him freedom to reshape the company. Subramaniam is on this week's episode of "The David Rubenstein Show: Peer to Peer Conversations." This interview was recorded April 29 at the Economic Club of Washington.

United Maritime (NASDAQ:USEA) reported a sharp reduction in its first-quarter net loss alongside a return to positive adjusted earnings, driven by a strategic fleet reallocation into the higher-earning Capesize dry bulk sector and substantial capital recycling.

Cosmos Health (NASDAQ:COSM) generated record revenue in the first quarter of 2026, driven by sustained distribution gains and market expansions, even as a shifting business mix and operational investments weighed on bottom-line profitability.

Williams-Sonoma (NYSE:WSM) reported solid top-line momentum for its first fiscal quarter, driven by positive comparable brand revenue across its portfolio, though elevated import tariff expenses weighed on the retailer's gross margins.

Immix Biopharma (NASDAQ:IMMX) announced a highly favorable interim update from its ongoing registrational Phase 2 NEXICART-2 clinical trial, showing that its investigational CAR-T cell therapy, NXC-201, achieved a 95% complete response rate in patients with relapsed or refractory AL Amyloidosis.

HUTCHMED (NASDAQ:HCM) and Innovent Biologics jointly announced that China’s National Medical Products Administration has approved the combination of ELUNATE® (fruquintinib) and TYVYT® (sintilimab injection) for the treatment of adults with advanced kidney cancer.

Scienjoy (NASDAQ:SJ) reported a successful turnaround in its bottom-line profitability for the first quarter of 2026, recovering from a prior-year loss even as total revenues experienced a moderate single-digit contraction.

US initial jobless claims for the week ending May 16 fell by 3,000 to 209,000. US housing starts declined in April as construction of single-family homes dropped by the most in nearly a year. Bloomberg's Michael McKee has this morning's economic data.